tm logo
ABDERA THERAPEUTICS
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 14 Aug 2024

Last Applicant/ Owned by

2405 Wesbrook Mall, 4th Floor

Vancouver, BC

CA

V6T1Z3

Serial Number

97240018 filed on 26th Jan 2022

Registration Number

N/A

Correspondent Address

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI

PALO ALTO, CA 94304-1050

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ABDERA THERAPEUTICS

pharmaceutical drug development services, namely, drug development for the treatment of cancer; research and development of pharmaceutical products using radiotherapy to target and treat tumors and cancer medical kits comprised of medical syringes and single and multi-dose vials of glass, sold empty, for administering pharmaceutical products used for the treatment, prevention, and diagnosis of ca Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


pharmaceutical drug development services, namely, drug development for the treatment of cancer; research and development of pharmaceutical products using radiotherapy to target and treat tumors and cancer


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [010]
Medical Instrument Products


medical kits comprised of medical syringes and single and multi-dose vials of glass, sold empty, for administering pharmaceutical products used for the treatment, prevention, and diagnosis of cancer


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


chemicals for pharmaceutical use, namely, for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs used for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products used for the treatment, prevention, and diagnosis of cancer; pharmaceutical products for use in relation to radiotherapy, namely, products to target and treat tumors and cancer; pharmaceutical preparations, namely, pharmaceuticals using alpha radiation therapies for the treatment of cancer; diagnostic imaging agents for use in diagnosing cancer


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97240018

Mark Type

No Service Mark

Attorney Docket Number

No 60924-TM1001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
14th Aug 2024SOU EXTENSION 2 FILED
14th Aug 2024SOU EXTENSION 2 GRANTED
14th Aug 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14th Aug 2024SOU TEAS EXTENSION RECEIVED
15th Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14th Feb 2024SOU EXTENSION 1 GRANTED
14th Feb 2024SOU EXTENSION 1 FILED
14th Feb 2024SOU TEAS EXTENSION RECEIVED
15th Aug 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
20th Jun 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED